Acute Management of Severe Asthma Exacerbation
For severe asthma exacerbations, immediately administer high-dose albuterol (2.5-5 mg nebulized or 4-8 puffs via MDI with spacer every 20 minutes for 3 doses), add ipratropium bromide (0.5 mg nebulized every 20 minutes for 3 doses), and give oral prednisone 40-60 mg as a single dose—continuing this regimen for 5-10 days without tapering. 1, 2, 3
Immediate Bronchodilator Therapy
Administer albuterol 2.5-5 mg via nebulizer or 4-8 puffs via MDI with spacer every 20 minutes for the first hour (3 total doses), then reassess clinical response 1, 3, 4
Add ipratropium bromide 0.5 mg (adults) or 0.25-0.5 mg (children) to albuterol every 20 minutes for 3 doses in moderate-to-severe exacerbations, as this combination reduces hospitalizations 1, 3, 5
The combination of albuterol plus ipratropium should be used for up to 3 hours in initial management of severe exacerbations, but adding ipratropium provides no further benefit once the patient is hospitalized 1
After the initial 3 doses, continue albuterol as needed based on clinical response, typically every 1-4 hours 1, 4
Systemic Corticosteroid Administration
Give oral prednisone 40-60 mg immediately as a single dose or in 2 divided doses, continuing daily for 5-10 days without tapering 1, 2, 3
Start corticosteroids early—within the first hour of presentation—as anti-inflammatory effects require 6-12 hours to become apparent 3, 6
Oral prednisone is equally effective as IV methylprednisolone and should be used unless the patient is vomiting or severely ill 2, 7, 3
For children, use prednisone 1-2 mg/kg/day in 2 divided doses (maximum 60 mg/day) for 3-10 days 1, 7, 3
No tapering is necessary for courses <7-10 days, especially if the patient is on inhaled corticosteroids 1, 2, 7
If IM route is absolutely necessary (persistent vomiting), use hydrocortisone 200 mg IM initially, then 200 mg every 6 hours—but reserve this only for patients who cannot tolerate oral medications 2
Oxygen Therapy and Monitoring
Maintain oxygen saturation >90% (>95% in pregnant women and patients with heart disease) via nasal cannula or mask 3
Measure peak expiratory flow (PEF) or FEV1 at baseline, 15-30 minutes after starting treatment, and then according to response 3
Continue treatment until PEF reaches 70% of predicted or personal best 1, 3
Reassess after initial bronchodilator dose and again after 60-90 minutes of therapy for clinical improvement including reduced work of breathing, decreased respiratory rate, and improved peak flow 3, 4
Adjunctive Therapies for Severe/Refractory Cases
Consider IV magnesium sulfate 2 g over 20 minutes (adults) or 25-75 mg/kg up to 2 g (children) for severe exacerbations not responding to initial therapy, as this reduces hospitalizations 1, 5
Heliox-driven albuterol nebulization can be considered in patients with severe disease who do not respond to standard therapies, though evidence is limited 1, 5
IV beta-agonists are largely unproven and not recommended due to lack of superiority over inhaled therapy and increased risk of adverse effects 1
Critical Decision Points for Escalation
Transfer to acute care facility if the patient shows signs of impending respiratory failure: exhaustion despite maximal therapy, deteriorating mental status, refractory hypoxemia, increasing hypercapnia, or hemodynamic instability 1, 8
Intubation should be performed semi-electively before respiratory arrest occurs—once deemed necessary, do not delay and perform in the ED with subsequent ICU transfer 1, 8
Consultation with a physician expert in ventilator management is essential, as ventilation of severe asthmatics is complicated by risk of barotrauma, hypotension from hyperinflation, and pneumothorax 1, 9, 8
Common Pitfalls to Avoid
Do not underdose corticosteroids—the commonly prescribed methylprednisolone dose pack provides only the equivalent of 105 mg prednisone total, which is inadequate 7
Do not default to IM steroids—oral administration is equally effective, less invasive, and allows easier dose adjustment 2, 7
Do not delay corticosteroid administration, as this reduces effectiveness and increases risk of clinical deterioration 7, 3
Do not continue ipratropium beyond the initial 3 hours or after hospital admission, as it provides no additional benefit 1
Avoid using leukotriene modifiers, theophylline, or inhaled corticosteroids alone as primary therapy for acute exacerbations—these have minimal role in acute management 1, 6, 5